scispace - formally typeset
Search or ask a question

Showing papers by "Janet B. W. Williams published in 2013"

Reference Entry•DOI•
Diagnostic and Statistical Manual of Mental Disorders

[...]

Janet B. W. Williams
11 Jun 2013

113,134 citations

Journal Article•DOI•
2210 – A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder using central ratings

[...]

D. Popp, Ronald M. Burch, Janet B. W. Williams1, L.M. Price, M.J. Detke2 •
Columbia University1, Indiana University – Purdue University Indianapolis2
01 Jan 2013-European Psychiatry
TL;DR: This study suggests that GLYX-13, an NMDA receptor glycine site functional partial agonist, rapidly reduces depression scores without eliciting psychotomimetic effects at therapeutic doses as assessed by central raters.

1 citations

Journal Article•DOI•
1922 – The evaluation of negative symptoms by videoconferencing in a clinical trial

[...]

Janet B. W. Williams1, D. Popp, Deenah Osman, E.A. Cohen, M.J. Detke2 •
Columbia University1, Indiana University – Purdue University Indianapolis2
01 Jan 2013-European Psychiatry
TL;DR: Excellent item-level ICCs for the NSA suggest that negative symptoms can be rated reliably by videoconferencing using well-calibrated blinded independent raters.

1 citations